Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANRS153TREVE: Raltegravir in HIV-1 Infected Patients After Renal Transplantation
NCT01453192Phase 3Completed
- Sponsor
- ANRS
- Start
- Dec 2011
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of raltegravir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ANRS. Started Dec 2011; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01453192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01453192.